Key facts
- It has raised $7.3M across 1 recorded rounds; the latest was Seed Round ($1.6M) in Oct 2021.
- Notable investors include Innovate UK, SOSV, Metaplanet Holdings, IndieBio, Johnson & Johnson Innovation - JLABS — 15 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Sequential
Funding rounds
1 roundsAbout Sequential
Developer of a microbiome testing and formulation platform designed to advance consumer skin microbiome analysis and research. The company's platform supports clinical study design, participant recruitment, non-invasive sampling, sequencing, and qPCR analysis, biomarker discovery, data interpretation, and in vivo microbiome certification, enabling the personal care, beauty, and pharmaceutical brands to generate science-backed claims and differentiate products.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 18
- Website
- sequential.bio/
- Ownership
- Privately Held (backing)
Sequential doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sequential shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sequential in its N-PORT filings yet. We sweep new filings monthly.